PUBLISHER: BCC Research | PRODUCT CODE: 1221579
PUBLISHER: BCC Research | PRODUCT CODE: 1221579
The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.
Market for commercial production and lot release testing is estimated to increase from $3.7 billion in 2022 to reach $9.1 billion by 2027, at a CAGR of 20.0% from 2022 through 2027.
Market for clinical development testing is estimated to increase from $2.4 billion in 2022 to reach $5.9 billion by 2027, at a CAGR of 19.8% from 2022 through 2027.
This report aims to provide a comprehensive study of the global market for biologics safety testing, both in terms of quantitative and qualitative data, to help develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding biologics safety testing products and services. Biologics safety testing includes biosafety testing & characterization of raw materials, cell bank & virus seeds, unprocessed bulks/viral harvests, and drug substance/product.
This report segments the global biologics safety testing market by application, test application, testing technology, and region of operations. BCC Research analyses each market and its applications, regulatory environments, technology, market projections, and market share. Industry growth drivers, restraints, trends, and opportunities in the biological safety testing market are also discussed in detail. The report also provides information on the competitive landscape, elaborate company profiles, and the impact of COVID-19 on the biologics safety testing market.